These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7105520)

  • 1. Combination chemotherapy with adriamycin and 5-fluorouracil in advanced bladder carcinoma.
    Veronesi A; Magri MD; Figoli F; Tirelli U; Galligioni E; Trovò MG; Merlo A; Dal Bò V; Tumolo S; Grigoletto E
    Clin Oncol; 1982 Jun; 8(2):103-6. PubMed ID: 7105520
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
    Sulkes A; Fuks Z
    Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined adriamycin and 5-fluorouracil therapy in the treatment of advanced cancer of the bladder (author's transl)].
    Marcuello Gaspar E; Germá Lluch JR; Dorca Ribugent J; López Pousa A; Español Llorens J; Abad Esteve A; Avella Mestre A
    Med Clin (Barc); 1982 Jul 1-31; 79(3):107-9. PubMed ID: 7109765
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined therapy with 5-fluorouracil, doxorubicin, cis-diamminedichloroplatinum on advanced urothelial cancer].
    Kawai T; Washizuka M; Kihara K; Takahashi T; Sakata Y; Tai K; Nagayama T; Okada K; Kusuyama H; Ishii Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):40-6. PubMed ID: 3611890
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study.
    Gagliano RG; Stephens RL; Costanzi JJ; Oishi N; Stuckey WJ; Grozea PN; Frank J; Crawford ED
    Cancer Treat Rep; 1984; 68(7-8):1025-6. PubMed ID: 6430559
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil.
    Robinson MR; Smith PH; Macaluso MP; Mulder JH; Martínez-Pinéiro JA; Cifuentes-Delatte L; Bono A; Glashan RW
    Eur Urol; 1977; 3(5):276-8. PubMed ID: 913456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer].
    Dunchik VN; Drozdovskiĭ BIa; Kariakin OB; Grishin GN
    Urol Nefrol (Mosk); 1985; (2):19-23. PubMed ID: 3992752
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intraarterial chemotherapy via reservoir system for far-advanced bladder and prostate cancer].
    Takahashi Y; Yamamoto N; Deguchi T; Kuriyama M; Yoh M; Yasuda M; Nakano M; Kawada Y; Takeuchi T; Shinoda I
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1310-3. PubMed ID: 9703815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy of metastatic bladder cancer.
    Yagoda A
    Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of 5-fluorouracil and adriamycin in transitional cell carcinoma of the urinary tract.
    Martino S; Samal B; Al-Sarraf M
    Cancer Treat Rep; 1980 Jan; 64(1):161-3. PubMed ID: 7379051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy.
    Richards B; Bastable JR; Freedman L; Glashan RW; Harris G; Newling DW; Robinson MR; Smith PH
    Br J Urol; 1983 Aug; 55(4):386-91. PubMed ID: 6349744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil and interferon-alpha in chemotherapy refractory bladder carcinoma: an effective regimen.
    Logothetis CJ; Hossan E; Recondo G; Sella A; Ellerhorst J; Kilbourn R; Zukiwski A; Amato R
    Anticancer Res; 1994; 14(3B):1265-9. PubMed ID: 8067694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal scheduling of interleukin 12 and chemotherapy in the murine MB-49 bladder carcinoma and B16 melanoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Clin Cancer Res; 1997 Sep; 3(9):1661-7. PubMed ID: 9815857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH; Johnson DE; Holoye PY; Samuels ML
    Cancer Treat Rep; 1977; 61(1):87-8. PubMed ID: 324624
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
    Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial infusion of 5-FU as a therapeutic adjunct in the treatment of advanced carcinoma of bladder and prostate.
    Nevin JE; Melnick I; Baggerly JT; Landes R; Easley CA
    Va Med Mon (1918); 1975 Aug; 102(8):614-20. PubMed ID: 1163099
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II study of adriamycin, 5-fluorouracil, levamisole, and irradiation in carcinoma of the bladder.
    Lundbeck F; Christophersen IS
    Cancer Treat Rep; 1979 Feb; 63(2):183-8. PubMed ID: 445495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.